{"name":"Elena N.Parovichnikova","slug":"elena-n-parovichnikova","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"R-BL-M-04","genericName":"R-BL-M-04","slug":"r-bl-m-04","indication":"unknown","status":"phase_3"},{"name":"R-BL-M-04 + auto-SCT","genericName":"R-BL-M-04 + auto-SCT","slug":"r-bl-m-04-auto-sct","indication":"Conditioning regimen for auto-SCT","status":"phase_3"}]}],"pipeline":[{"name":"R-BL-M-04","genericName":"R-BL-M-04","slug":"r-bl-m-04","phase":"phase_3","mechanism":"R-BL-M-04 is a small molecule drug that targets the molecular target.","indications":["unknown"],"catalyst":""},{"name":"R-BL-M-04 + auto-SCT","genericName":"R-BL-M-04 + auto-SCT","slug":"r-bl-m-04-auto-sct","phase":"phase_3","mechanism":"R-BL-M-04 is a conditioning regimen for auto-SCT, which involves the use of a specific chemotherapy regimen to prepare the patient's body for a stem cell transplant.","indications":["Conditioning regimen for auto-SCT"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBLTFh5X2M4MEtFR3U4XzJGdHpfeW1HM3k5eUxrS3lIeDlqdl9fYUs3amZ0ZWFJcTVnc3lpNDFqNWxndGptWmwzWEtHaUl4dmdDVGY0N1p2M1FwNXNzcV9XR28yZlZxLXJNd24xOGFR?oc=5","date":"2020-10-14","type":"pipeline","source":"Wiley Online Library","summary":"Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes - Wiley Online Library","headline":"Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}